GLENMARK - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.7

📉 GLENMARK shows weak momentum but strong earnings and institutional support. Suitable for cautious intraday scalping near support zones.

🔍 Positive

• Quarterly PAT surged from ₹269 Cr. to ₹596 Cr., showing strong earnings growth.
• EPS of ₹52.7 and P/E of 27.8 are attractive compared to industry average (33.1).
• ROCE (9.72%) and ROE (7.35%) reflect improving operational efficiency.
• DII holding increased by 0.97%, indicating strong domestic institutional support.
• Debt-to-equity ratio of 0.03 suggests financial stability.

⚠️ Limitation

• MACD negative (-30.9) and RSI at 38.8 indicate weak momentum.
• Current price below 50 DMA (₹1,925) implies short-term bearish bias.
• Volume (7.15L) slightly below 1-week average (7.58L), showing reduced intraday interest.
• PEG ratio of 13.9 suggests overvaluation relative to growth.

📰 Company Negative News

• Stock trading below 50 DMA with weak RSI and MACD signals caution for momentum traders.

📢 Company Positive News

• Strong quarterly profit growth and increased DII holding reflect improving fundamentals and institutional confidence.

🏭 Industry

• Pharmaceutical sector benefits from consistent demand and regulatory tailwinds but faces pricing and margin pressures.
• Industry P/E of 33.1 reflects moderate optimism across peers.

🧾 Conclusion

• GLENMARK offers a cautious intraday setup with strong earnings and institutional support.
• Best suited for scalping trades near support with tight stop loss and defined exit levels.
• Monitor RSI and MACD for signs of reversal before entering aggressively.

I can track GLENMARK’s RSI and MACD live to alert you when momentum strengthens for a safer entry.